A detailed history of Stone Run Capital, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Stone Run Capital, LLC holds 13,307 shares of TMO stock, worth $8.13 Million. This represents 2.94% of its overall portfolio holdings.

Number of Shares
13,307
Previous 13,807 3.62%
Holding current value
$8.13 Million
Previous $8.02 Billion 8.3%
% of portfolio
2.94%
Previous 3.07%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$541.52 - $599.02 $270,760 - $299,510
-500 Reduced 3.62%
13,307 $7.36 Billion
Q1 2024

May 14, 2024

SELL
$528.82 - $599.43 $264,410 - $299,715
-500 Reduced 3.49%
13,807 $8.02 Billion
Q4 2023

Feb 14, 2024

SELL
$431.41 - $532.94 $306,301 - $378,387
-710 Reduced 4.73%
14,307 $7.59 Billion
Q3 2023

Nov 14, 2023

BUY
$498.29 - $574.41 $7.48 Million - $8.63 Million
15,017 New
15,017 $7.6 Billion
Q2 2023

Aug 14, 2023

BUY
$508.46 - $591.13 $12,711 - $14,778
25 Added 0.17%
14,992 $7.82 Million
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $321,000 - $362,892
-600 Reduced 3.85%
14,967 $8.63 Million
Q4 2022

Feb 14, 2023

SELL
$484.71 - $571.37 $436,239 - $514,233
-900 Reduced 5.47%
15,567 $8.57 Million
Q3 2022

Nov 14, 2022

BUY
$507.19 - $604.49 $2,535 - $3,022
5 Added 0.03%
16,467 $8.35 Million
Q2 2022

Aug 15, 2022

SELL
$500.9 - $612.21 $668,701 - $817,300
-1,335 Reduced 7.5%
16,462 $8.94 Million
Q1 2022

May 16, 2022

SELL
$524.0 - $644.92 $292,392 - $359,865
-558 Reduced 3.04%
17,797 $10.5 Million
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $503,565 - $590,507
-885 Reduced 4.6%
18,355 $12.2 Million
Q3 2021

Nov 15, 2021

BUY
$509.53 - $609.78 $277,693 - $332,330
545 Added 2.92%
19,240 $11 Million
Q2 2021

Aug 16, 2021

BUY
$441.0 - $508.24 $56,007 - $64,546
127 Added 0.68%
18,695 $9.43 Million
Q1 2021

May 17, 2021

SELL
$439.85 - $518.83 $483,835 - $570,713
-1,100 Reduced 5.59%
18,568 $8.47 Million
Q4 2020

Feb 16, 2021

SELL
$435.06 - $527.66 $255,380 - $309,736
-587 Reduced 2.9%
19,668 $9.16 Million
Q3 2020

Nov 13, 2020

BUY
$359.77 - $441.52 $59,362 - $72,850
165 Added 0.82%
20,255 $8.94 Million
Q2 2020

Aug 14, 2020

BUY
$275.2 - $362.34 $46,784 - $61,597
170 Added 0.85%
20,090 $7.28 Million
Q1 2020

May 15, 2020

SELL
$255.3 - $340.05 $788,877 - $1.05 Million
-3,090 Reduced 13.43%
19,920 $5.65 Million
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $261,052 - $314,918
-960 Reduced 4.01%
23,010 $7.48 Million
Q3 2019

Nov 14, 2019

BUY
$268.46 - $305.43 $268,460 - $305,430
1,000 Added 4.35%
23,970 $6.98 Million
Q2 2019

Aug 14, 2019

BUY
$257.51 - $295.55 $38,626 - $44,332
150 Added 0.66%
22,970 $6.75 Million
Q4 2018

Feb 14, 2019

SELL
$208.47 - $251.98 $302,281 - $365,371
-1,450 Reduced 5.97%
22,820 $5.11 Million
Q3 2018

Nov 14, 2018

SELL
$205.57 - $244.32 $10,278 - $12,216
-50 Reduced 0.21%
24,270 $5.92 Million
Q2 2018

Aug 14, 2018

BUY
$203.14 - $219.53 $40,628 - $43,906
200 Added 0.83%
24,320 $5.04 Million
Q1 2018

May 14, 2018

SELL
$192.98 - $224.11 $14,473 - $16,808
-75 Reduced 0.31%
24,120 $4.98 Million
Q4 2017

Feb 15, 2018

SELL
$182.03 - $200.37 $9,101 - $10,018
-50 Reduced 0.21%
24,195 $4.59 Million
Q3 2017

Nov 14, 2017

BUY
$171.74 - $194.04 $4.16 Million - $4.7 Million
24,245
24,245 $4.59 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $240B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Stone Run Capital, LLC Portfolio

Follow Stone Run Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone Run Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone Run Capital, LLC with notifications on news.